Ayahuasca or esketamine: which eases depression better?

NCT ID NCT07212946

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether four weekly doses of ayahuasca (a plant-based psychedelic drink) or esketamine (a nasal spray) could reduce symptoms in 22 adults with severe major depression. Participants were randomly assigned to one treatment, and their depression levels were tracked using a standard questionnaire. The goal was to see which approach works better for easing depression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSION SEVERE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital das Clínicas da FMRP-USP

    Ribeirão Preto, São Paulo, 14049900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.